Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Safety Observation of COVID19 Vaccine in a Large Population

NCT05890521 is registered in ClinicalTrials.gov with Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. as lead sponsor.

NCT NCT05890521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Safety Observation of COVID19 Vaccine in a Large Population
Lead sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
April 2, 2022
Completion date
June 30, 2023
Enrollment
100,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19